IRCT20240224061102N1尚未招募3 期
Evaluation of the effect of edaravone on the patients with ischemic stroke
Yasouj University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Participants with ischemic stroke based on clinical symptoms and CT scan
- •Participants with ischemic stroke and NIHSS score of 16
排除标准
- •Unwillingness to participate
- •Significant cognitive and neurological impairments
- •Presence of hemorrhagic stroke
研究者
相似试验
已完成
不适用
Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis (ALS)JPRN-UMIN000024854Okayama university20
已完成
3 期
Edaravone in COVID-19IRCT20200317046797N6Tabriz University of Medical Sciences30
招募中
3 期
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
招募中
2 期
Effect of Edaravone in treatment of ALSAmyotrophic Lateral Sclerosis.Progressive muscular atrophyRestrictive lung disease due to amyotrophic lateral sclerosisRestrictive lung mechanics due to alsG12.21IRCT20190324043105N1Esfahan University of Medical Sciences20
已完成
不适用
Safety and efficacy of Edaravone[Nichiiko] in patients with acute noncardiogenic brain embolismacute noncardiogenic brain embolismJPRN-UMIN000004597Takeshi Yamada20